6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-3-methyl -1H-benzimidazole;Pantoprazole Impurity 30(Pantoprazole EP Impurity F);Pantoprazole impurity 3/Pantoprazole EP Impurity F/6-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole;6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1-methylbenzimidazole;Pantoprazole-4;Pantoprazole related compound F;Pantoprazole Ep Imp F;1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1-methyl-
6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1-methyl-1H-benzimidazole was used in the study of chemistry of covalent inhibition of gastric ATPase by proton pump inhibitors.
Pantoprazole EP Impurity F Preparation Products And Raw materials